Tesamorelin 1kits (10Vials)

Tesamorelin – Detailed Introduction & Benefits (English) Basic Introduction Tesamorelin (brand name: Egrifta SV ) is a synthetic, stabilized analog of human Growth Hormone-Releasing Hormone (GHRH) . Classification : 44‑amino‑acid peptide with an N‑terminal trans‑3‑hexenoic acid modification. Developer : Theratechnologies Inc. (Canada). FDA Approval : 2010, for reducing excess visceral abdominal fat in HIV‑infected adults with lipodystrophy. Key feature : Resists degradation by DPP‑IV , far more stable and potent than native GHRH. Administration : Subcutaneous injection (once daily). Half‑life : ~8–38 minutes; short‑acting but triggers robust, pulsatile GH release. Mechanism of Action GHRH Receptor Agonist : Binds selectively to GHRH receptors on pituitary somatotroph cells. Natural GH Pulse : Stimulates synthesis and pulsatile release of endogenous GH , mimicking the body’s natural rhythm. IGF‑1 Elevation : GH drives liver and tissue production of IGF‑1 , the key mediator of GH’s anabolic/lipolytic effects. Visceral Lipolysis : Activates hormone‑sensitive lipase (HSL) in adipocytes, preferentially breaking down visceral (abdominal) fat over subcutaneous fat. Preserves Feedback : Unlike exogenous HGH, it does not suppress the hypothalamic‑pituitary‑adrenal (HPA) axis ; amplifies natural GH regulation. Main Benefits 1. Reduction of Visceral Abdominal Fat (Primary Indication) FDA‑proven : Significantly reduces visceral adipose tissue (VAT) in HIV‑associated lipodystrophy. Targeted fat loss : Reduces dangerous belly fat linked to insulin resistance, metabolic syndrome, and cardiovascular risk. Body recomposition : Improves waist circumference and abdominal contour without muscle loss. 2. Growth Hormone & IGF‑1 Optimization Restores youthful GH pulsatility : Reverses age‑related GH/IGF‑1 decline (somatopause). Elevates IGF‑1 : Boosts IGF‑1 levels to support metabolism, muscle, and tissue repair. Safe GH stimulation : Avoids supraphysiological GH spikes seen with direct HGH use. 3. Metabolic Health & Insulin Sensitivity Improves glucose regulation : Enhances insulin sensitivity and glucose uptake in peripheral tissues National Center for Biotechnology Information . Lowers triglycerides : Reduces hepatic lipogenesis and circulating triglyceride levels. Supports liver health : Reduces visceral fat and hepatic steatosis (fatty liver risk). 4. Lean Muscle & Physical Performance Anabolic support : Promotes muscle protein synthesis and preserves lean mass during fat loss. Strength & recovery : May improve exercise endurance, reduce fatigue, and accelerate muscle repair. Anti‑catabolic : Counters age‑related muscle wasting (sarcopenia). 5. Anti‑Aging & Longevity Cellular repair : Boosts IGF‑1‑mediated tissue regeneration and reduces senescence. Skin health : May improve elasticity, reduce fine lines, and enhance collagen synthesis. Energy & vitality : Enhances daily energy, mental clarity, and sleep quality. 6. Cardiovascular Protection Reduces cardiac risk : Targets visceral adiposity, a major driver of heart disease. Improves lipid profile : Lowers LDL (“bad” cholesterol) and raises HDL (“good” cholesterol). Endothelial support : May improve blood vessel function and reduce inflammation. Key Advantages Over Other GHRPs/GHRHs Full‑length GHRH (1–44) : More potent than truncated analogs (e.g., Sermorelin 1–29). DPP‑IV resistance : Longer half‑life and more consistent GH pulses. Visceral fat specificity : Superior for reducing abdominal/visceral fat vs. GHRP‑2/GHRP‑6. Minimal hunger : Unlike GHRP‑6, no significant appetite increase . Common Off‑Label Uses General abdominal/visceral fat loss Anti‑aging & longevity protocols Body recomposition (preserve muscle, reduce fat) Metabolic syndrome/insulin resistance support Age‑related GH decline (somatopause) Safety Note Contraindicated in pregnancy, active malignancy, and uncontrolled diabetes. May cause mild injection‑site reactions, headache, or joint pain (usually transient).